Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 67Lung Neoplasms 29Brain Neoplasms 11Head and Neck Neoplasms 10Neoplasms 9Esophageal Neoplasms 9Breast Neoplasms 8Adenocarcinoma of Lung 8Adenocarcinoma Of Esophagus 7Glioblastoma 6Gliosarcoma 5Esophageal Squamous Cell Carcinoma 5NSCLC 4Central Nervous System Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Colonic Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Stomach Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Neuroblastoma 2Lymphoid Interstitial Pneumonia 2Laryngeal Diseases 2Glioma 2

Interventions

Iodine-131 5dabrafenib 4Vemurafenib 4Magnetic Resonance Spectroscopy 4trametinib 3lenvatinib 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Thyroidectomy 3selpercatinib 2cobimetinib 2X-Rays 2Thyroid (USP) 2Surgical Procedures, Operative 2Sunitinib 2Specimen Handling 2Radiofrequency Ablation 2Interviews as Topic 2vandetanib 1tremelimumab 1spartalizumab 1pembrolizumab 1pazopanib 1durvalumab 1delta 24-sterol reductase 1copanlisib 1cabozantinib 1Whole Body Imaging 1Thyrotropin 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thyroid Cancer, Papillary × Gefitinib × Clear all
NCT00095836 2017-05-31

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

Massachusetts General Hospital

Phase 2 Completed
27 enrolled 16 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡